Non-Surgical Weight Loss & Wellness Program

Weight Loss Medications

Weight loss medications are prescription treatments that help regulate appetite and metabolism so weight loss becomes achievable and sustainable.

If diet and exercise haven’t moved the needle, you are not alone, and you have not failed. At The Bariatric Experts™, we prescribe, dose, and monitor weight loss medications inside a bariatric and metabolic surgery practice. This is not a five-minute video visit.

We care for patients across Frisco and the greater DFW area. You deserve a medical weight loss plan that works with your biology, not against it. Obesity is a chronic disease, and we treat it like one.

What Are Weight Loss Medications?

We choose your medication with you, based on your health history, your goals, and our clinical judgment. Every medication works alongside nutrition and activity changes to treat obesity as the chronic disease it is. Below, we walk through semaglutide, tirzepatide, retatrutide, and phentermine. This is not a diet plan, and it is not a supplement. It is medical treatment for a biological condition that changes how your body regulates hunger, fullness, and fat storage.

What makes our program different is who stands behind it. The same team that manages complex bariatric and metabolic surgery patients builds your medication plan. We watch your labs and track your response. If medication alone gets you where you want to go, wonderful. If it does not, you are already in the right place.

How Do Weight Loss Medications Work in the Body?

Most of today’s medications are built on gut hormones your body already makes. GLP-1 and GIP are released after you eat. They tell your brain you’re satisfied and slow your stomach’s emptying.

These hormones also help your body use insulin more efficiently. Medications that activate the same receptors turn up the volume on those signals. In people with obesity, those signals are often too quiet.

Patients describe the change the same way: the constant mental chatter about food gets quieter. Oral medications like phentermine work through a different route. They act on brain chemistry that governs appetite and cravings. That makes them a better fit for some patients, or a useful addition.

Which Weight Loss Medications Do You Offer?

Every plan starts with a conversation, not a prescription pad. Here is what we prescribe, and why we might recommend one over another.

Semaglutide (Wegovy®, Ozempic®)

Semaglutide is a once-weekly injection that activates the GLP-1 receptor. In the 68-week STEP 1 trial, adults taking semaglutide 2.4 mg lost 14.9% on average compared with 2.4% on placebo. Roughly half reached a reduction of 15% or more.

It is approved for adults with a BMI of 30 or higher. A BMI of 27 or higher also qualifies if you have a weight-related condition. That includes type 2 diabetes, high blood pressure, or sleep apnea. Semaglutide is often a strong starting point for patients who want the longest track record behind them.

Tirzepatide (Zepbound®, Mounjaro®)

Tirzepatide is also a once-weekly injection, but it activates two receptors instead of one, GLP-1 and GIP. In the 72-week SURMOUNT-1 trial, participants on the 15 mg dose lost 20.9% on average. Fifty-seven percent lost at least 20%.

That dual action can matter for patients with insulin resistance and for those who stalled on a single-pathway medication. It carries the same BMI criteria as semaglutide. Which one we recommend depends on your history, your other medications, your tolerance, and your goals.

Retatrutide

Retatrutide is a new once-weekly injection that works on three of your body’s hormone signals instead of one or two. It is not yet FDA approved.

In an early study, people on the highest doselost 24.2% on average. It is now being tested in a much larger program with more than5,800 people.

We offer retatrutide to patients our providers determine are good candidates.

Compounded Phentermine and Other Oral Medications

Not everyone needs or wants a weekly injection. Your provider may recommend a compounded formulation when it is the right fit for you. Compounded phentermine is one example. Compounded medications arenot FDA approved.

Phentermine is an appetite suppressant forshort-term use. It remains a useful, accessible tool for the right patient. Combination pills extend what oral therapy can do. In the 56-week CONQUER trial, the higher dose of phentermine plus topiramateproduced 9.8% average loss versus 1.2% with placebo.

Why Do Some Patients Need More Than One Medication?

This is one of the most useful things we can tell you. Almost nobody puts it on a website: these medications do not behave the same way in every body.

A 2026 review of response data found that about 10% of patients in controlled trials never reach 5% weight loss. That’s true for both GLP-1 and dual-agonist medications. Real-world results are less consistent than trial averages suggest.

How you respond in the first few months is the most actionable predictor of where you will land. Other patients do beautifully at first and then stall. That is not something you did wrong. It is biology adapting, and it is a normal part of treating a chronic disease.

When it happens, we have moves to make. We can optimize your dose or switch you to a different mechanism. In some cases, we add a second medication that works on a separate pathway. Evidence for combination approaches is still developing. We make those calls carefully, one patient at a time, with labs and close follow-up behind the decision.

portrait of overweight man in nature

Am I a Good Candidate for Weight Loss Medication?

You may be a good candidate for medical weight loss if:

  • You have tried structured eating and exercise plans without lasting results
  • You are not ready for weight loss surgery, or you do not qualify, but you need more than lifestyle changes alone
  • You had bariatric surgery in the past and are dealing with weight regain

Medication is not right for everyone. GLP-1 medications are not used during pregnancy. A personal or family history of medullary thyroid cancer, MEN 2, or pancreatitis changes the conversation. Your evaluation includes labs and a full medication review. If medication is not the safest path for you, we will say so and show you what is.

Not sure whether medication or surgery fits you best? See howsurgery and shots compare.

What Happens After I Start Treatment?

Your first appointment is a real conversation about your weight history, your health conditions, and your current medications. We also ask about everything you have already tried. Nobody leaves with a prescription they do not understand.

You start at a low dose and step up gradually. That titration is deliberate: it gives your body time to adjust and keeps side effects such as nausea manageable. We check in regularly to track progress, adjust dosing, and handle side effects before they become a reason to quit.

As you approach your goal, the conversation shifts to maintenance. Some patients stay on a lower dose long term, and others transition off with a structured plan. Either way, we build it with you.

Why Choose The Bariatric Experts for Non-Surgical Weight Loss?

You can get a GLP-1 prescription almost anywhere right now. An app will write one in ten minutes. So why come here?

Because weight is all we do, and because we can take you the whole way.

Our team is led by a founding Fellow of the American Society for Metabolic and Bariatric Surgery. That fellow is board-certified in bariatric surgery, with more than 30 years of surgical experience. Fifteen of those years have been dedicated exclusively to bariatric and metabolic surgery.

Our surgeons have performed over 7,000 weight loss surgeries and 1,400+ robotic procedures. They have built 3 separate bariatric programs to Center of Excellence status. Our physician assistants work directly with patients in our medical weight loss program and stay with you between visits.

You will not be handed off to a call center or a new provider every time you check in. The same team that builds your plan watches your labs and answers your questions. They adjust your dose personally when your body needs something different. You are never just a number here, and you will never be judged for needing help.

That depth matters most when the first plan does not work. Adjusting a dose, switching mechanisms, recognizing when someone needs something different: those are judgment calls, and judgment comes from volume. If medication is not enough on its own, we will not send you elsewhere to start over.

initial consultation with expert surgical doctor
"Nobody walks through our door having not tried. My job is to find the tool that fits your body, then keep adjusting until we get it right."
- Scott C. Stowers, D.O., FASMBS

Frequently Asked Questions

Weight loss medications are cash pay, and we do not bill insurance. Your cost depends on your medication and dose, and we go over it with you before you start.Financing options are available.

Most patients notice reduced appetite within the first few weeks. Meaningful weight change usually shows up across three to six months as the dose increases. The major trials ran 56 to 72 weeks, so think in seasons rather than weeks. We adjust if your response is slower than expected.

Nausea, diarrhea, constipation, and mild stomach discomfort are the most common effects of GLP-1 and dual-agonist medications. In the STEP 1 trial, nausea and diarrhea were transient and mild to moderate. Slow titration is designed to reduce them, and we adjust your plan if they are hard to manage.

Not necessarily, but obesity is a chronic disease and treatment usually needs to continue in some form. In the STEP 4 trial, patients who kept losing weight on continued semaglutide were compared with those switched to placebo. The placebo group regained a substantial portion. We plan for maintenance from the start. That may mean a lower dose, a different medication, or a structured transition with close follow-up.

Yes. Medication can be an effective tool for patients with weight regain after a sleeve, bypass, or band. Because your anatomy has changed, dosing and nutrition should be managed by a team that understands post-surgical physiology. That is what we do every day.

What Do Patients Say About Working With Us?

“Both the doctor and his nurse are amazing and very personable people. Very informative and make you feel like they care.”
Courtney C., Google Review ⭐⭐⭐⭐⭐
“The staff are the most passionate, efficient, and genuine medical professionals I have ever seen across all medical specialties. Their level of commitment to their patients is unmatched. They run a highly efficient office, and I truly feel that I cannot fail with them on my side. I cannot recommend this office enough. They are the absolute best in the business.”
J H, Google Review ⭐⭐⭐⭐⭐
“I had an excellent experience with The Bariatric Experts. From the very first consultation, the staff was knowledgeable, kind, and truly dedicated to helping patients succeed. They took the time to explain every step of the process in detail and made sure all of my questions were answered. The team is compassionate and supportive, offering not only medical guidance but also emotional encouragement throughout the journey.”
Drew & Kristie J., Google Review ⭐⭐⭐⭐⭐
“The staff are phenomenal! Each of them make you feel comfortable and treat you like family. I am incredibly thankful to them for helping me get my life back. From the start, they've been extremely helpful and compassionate. I've never had to sit back and ask myself if I'm going to hear from them, because they always check in, and that is amazing!”
Angela H., Google Review ⭐⭐⭐⭐⭐

1Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. https://doi.org/10.1056/NEJMoa2032183
2Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. https://doi.org/10.1056/NEJMoa2206038
3Jastreboff AM, et al. Triple-Hormone-Receptor Agonist Retatrutide for Obesity, A Phase 2 Trial. N Engl J Med. 2023;389(6):514-526. https://doi.org/10.1056/NEJMoa2301972
4Giblin K, et al. Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the TRIUMPH registrational clinical trials. Diabetes Obes Metab. 2025;28(1):83-93. https://doi.org/10.1111/dom.70209
6National Institute of Diabetes and Digestive and Kidney Diseases. Prescription Medications to Treat Overweight & Obesity. https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity
7Gadde KM, et al. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER). Lancet. 2011;377(9774):1341-52. https://doi.org/10.1016/S0140-6736(11)60205-5
8U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
9Kuryłowicz A, Czupryniak L. Responders Vs. Non-Responders or How to Predict the Response to GLP-1 or GLP-1/GIP Receptor Agonist Therapy. Diabetes Obes Metab. 2026. https://doi.org/10.1111/dom.71226
10MedlinePlus (NIH / National Library of Medicine). Semaglutide Injection. https://medlineplus.gov/druginfo/meds/a618008.html
11Rubino D, et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance: The STEP 4 Randomized Clinical Trial. JAMA. 2021;325(14):1414-1425. https://doi.org/10.1001/jama.2021.3224

This content has either been authored or reviewed and approved by the doctors at The Bariatric Experts

Page Updated: